Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Drug Discovery
1 of 3
Previous |
Next
Drug Discovery
Cell mates
Dr Ellen Feigal of TGen explains why the sequencing of the human genome is so revolutionary in understanding, diagnosing and treating cancer.
No Comments
From antigen sequence to antibody in record time
Two innovative technologies combined for the high-throughput generation of antigens and antibodies
No Comments
Faster innovation cycles through microfluidics technology
Kevin Hrusovsky, President and CEO, Caliper Life Sciences looks at a leading edge solution capable of addressing serious challenges in the drug discovery industry
No Comments
Challenges in next generation pharmacology need world-class science tools
Looking at the explosion of data and accompanying explosion in computing needs in the pharmaceutical industry
No Comments
Come together
Dennis Harney, PhD, Edward Hejlek and Timothy McBride take a closer look at Collaborative research and the CREATE Act
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.